Genome-editing medicinal products: the EMA perspective
Nat Rev Drug Discov
.
2024 Apr;23(4):242-243.
doi: 10.1038/d41573-024-00050-2.
Authors
Anna Tavridou
,
Dolça Rogers
,
Giada Farinelli
,
Iordanis Gravanis
,
Veronika Jekerle
PMID:
38491159
DOI:
10.1038/d41573-024-00050-2
No abstract available
Publication types
News
MeSH terms
CRISPR-Cas Systems
Gene Editing*
Genome*
Humans